<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39366117</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">2210-2612</ISSN><JournalIssue CitedMedium="Print"><Volume>124</Volume><PubDate><Year>2024</Year><Month>Oct</Month><Day>02</Day></PubDate></JournalIssue><Title>International journal of surgery case reports</Title><ISOAbbreviation>Int J Surg Case Rep</ISOAbbreviation></Journal><ArticleTitle>Refractory chylothorax following COVID-19: Successful surgical management of a rare complication; a case report.</ArticleTitle><Pagination><StartPage>110403</StartPage><MedlinePgn>110403</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">110403</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijscr.2024.110403</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2210-2612(24)01184-2</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND IMPORTANCE" NlmCategory="UNASSIGNED">Chylothorax is an uncommon complication linked to COVID-19. The fundamental pathophysiology and most effective management strategy are still uncertain.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 72-year-old man presented with worsening dyspnea and fatigue one month post-COVID-19. Imaging demonstrated a significant right pleural effusion, with thoracentesis confirming the presence of chylothorax. Despite the implementation of conservative interventions, the effusion remained unresolved. During the right thoracotomy procedure, a 1 cm (about 0.39 in) perforation in proximity to the Azygos vein, encircled by hypertrophic lymph nodes, was identified. Surgical intervention successfully alleviated the symptoms.</AbstractText><AbstractText Label="CLINICAL DISCUSSION" NlmCategory="UNASSIGNED">This case implies that mediastinal lymphadenopathy because of COVID-19 could potentially obstruct and interfere with the thoracic duct. This emphasizes the significance of considering chylothorax as a crucial diagnostic possibility in individuals presenting with new onset pleural effusions following COVID-19. Although conservative approaches are typically the first line of management, persistent cases may necessitate surgical intervention to target the root cause.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Additional research is imperative to elucidate the intricate pathways connecting COVID-19 and chylothorax, as well as to ascertain the most effective diagnostic and therapeutic approaches.</AbstractText><CopyrightInformation>Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ju</LastName><ForeName>Nasrin Rahmani</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Surgery, Farhikhtegan Research Center, Tehran Medical Sciences School Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fakhr</LastName><ForeName>Masoud Saadat</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tehran Medical Sciences School Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gholami</LastName><ForeName>Poorya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tehran Medical Sciences School Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khosravi</LastName><ForeName>Fatemeh</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tehran Medical Sciences School Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rezvanfar</LastName><ForeName>Kiana</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Tehran Medical Sciences School Branch, Islamic Azad University, Tehran, Iran. Electronic address: kianarezvanfar@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int J Surg Case Rep</MedlineTA><NlmUniqueID>101529872</NlmUniqueID><ISSNLinking>2210-2612</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chylothorax</Keyword><Keyword MajorTopicYN="N">Lymphadenopathy</Keyword><Keyword MajorTopicYN="N">Pleural effusion</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Thoracic duct</Keyword></KeywordList><CoiStatement>Conflict of interest statement The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>7</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39366117</ArticleId><ArticleId IdType="pmc">PMC11483476</ArticleId><ArticleId IdType="doi">10.1016/j.ijscr.2024.110403</ArticleId><ArticleId IdType="pii">S2210-2612(24)01184-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Braun C.M., Ryu J.H. Chylothorax and Pseudo chylothorax. Clin. Chest Med. 2021;42(4):667–675.</Citation><ArticleIdList><ArticleId IdType="pubmed">34774173</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley L.E., Ataya A. Clinical approach and review of causes of chylothorax. Respir. Med. 2019;157:7–13.</Citation><ArticleIdList><ArticleId IdType="pubmed">31454675</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A., Chaddha U., Kaul V., Desai A., Gillaspie E., Maldonado F. Multidisciplinary management of chylothorax. Chest. Dec 1, 2022;162(6):1402–1412.</Citation><ArticleIdList><ArticleId IdType="pubmed">35738344</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulle M.V., Puri H.V., Asaf B.B., Bishnoi S., Yadav A., Kumar A. Chylothorax-modalities of management and outcomes: a case series. Lung India. 2021;38(2):154–160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098887</ArticleId><ArticleId IdType="pubmed">33687010</ArticleId></ArticleIdList></Reference><Reference><Citation>Skouras V., Kalomenidis I. Chylothorax: diagnostic approach. Curr. Opin. Pulm. Med. 2010;16(4)</Citation><ArticleIdList><ArticleId IdType="pubmed">20410823</ArticleId></ArticleIdList></Reference><Reference><Citation>Guermazi A., Brice P., Hennequin C., Sarfati E. Lymphography: an old technique retains its usefulness. Radiographics. 2003;23(6):1541–1558.</Citation><ArticleIdList><ArticleId IdType="pubmed">14615563</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.Y., Hwang H.S., Lee H.Y., Cho J.H., Kim H.K., Lee K.S., et al. Anatomic and functional evaluation of central lymphatics with noninvasive magnetic resonance lymphangiography. Medicine (Baltimore) 2016;95(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4998379</ArticleId><ArticleId IdType="pubmed">27015184</ArticleId></ArticleIdList></Reference><Reference><Citation>Duletzke N.T., Kiraly L.N., Martindale R.G. Chylothorax and chylous ascites: overview, management, and nutrition. Nutr. Clin. Pract. 2023;38(3):557–563.</Citation><ArticleIdList><ArticleId IdType="pubmed">36938719</ArticleId></ArticleIdList></Reference><Reference><Citation>Schild H.H., Strassburg C.P., Welz A., Kalff J. Treatment options in patients with chylothorax. Dtsch. Arztebl. Int. 2013;110(48):819–826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3865492</ArticleId><ArticleId IdType="pubmed">24333368</ArticleId></ArticleIdList></Reference><Reference><Citation>Satriano F., Scioscia G., Cagnazzo M.G., Maci F., Refolo L., Fuso P., et al. Chylothorax found in a patient with COVID-19. Respirology Case Reports. 2022;10(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8783950</ArticleId><ArticleId IdType="pubmed">35096397</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohrabi C., Mathew G., Maria N., Kerwan A., Franchi T., Agha R.A. The SCARE 2023 guideline: updating consensus surgical CAse REport (SCARE) guidelines. Int J Surg Lond Engl. 2023;109(5):1136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10389401</ArticleId><ArticleId IdType="pubmed">37013953</ArticleId></ArticleIdList></Reference><Reference><Citation>Winer L.K., Salyer C., Beckmann N., Caldwell C.C., Nomellini V. Enigmatic role of coagulopathy among sepsis survivors: a review of coagulation abnormalities and their possible link to chronic critical illness. Trauma Surg. Acute Care Open. 2020;5(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7570228</ArticleId><ArticleId IdType="pubmed">33094168</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Keller T.T. E. Van Gorp, H. Ten Cate, infection and inflammation and the coagulation system. Cardiovasc. Res. 2003;60(1):26–39.</Citation><ArticleIdList><ArticleId IdType="pubmed">14522404</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley B., Naresh K.N., Roufosse C., Nicholson A.G., Weir J., Cooke G.S., Thursz M., Manousou P., Corbett R., Goldin R., Al-Sarraj S., Abdolrasouli A., Swann O.C., Baillon L., Penn R., Barclay W.S., Viola P., Osborn M. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020;1(6):e245–e253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7440861</ArticleId><ArticleId IdType="pubmed">32844161</ArticleId></ArticleIdList></Reference><Reference><Citation>Bompard F., Monnier H., Saab I., Tordjman M., Abdoul H., Fournier L., Sanchez O., Lorut C., Chassagnon G., Revel M.P. Pulmonary embolism in patients with COVID-19 pneumonia. Eur. Respir. J. 2020;56(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7236820</ArticleId><ArticleId IdType="pubmed">32398297</ArticleId></ArticleIdList></Reference><Reference><Citation>Price L.C., McCabe C., Garfield B., Wort S.J. Thrombosis and COVID-19 pneumonia: the clot thickens! Eur. Respir. J. 2020;56(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301830</ArticleId><ArticleId IdType="pubmed">32554532</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok F.A., Kruip M., van der Meer N.J.M., Arbous M.S., Gommers D., Kant K.M., Kaptein F.H.J., van Paassen J., Stals M.A.M., Huisman M.V., Endeman H. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145–147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle D., O’Donnell J.S., Sharif K., Emery P., Bridgewood C. Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2020;2(7):e437–e445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajendran P., Rengarajan T., Thangavel J., Nishigaki Y., Sakthisekaran D., Sethi G., Nishigaki I. The vascular endothelium and human diseases. Int. J. Biol. Sci. 2013;9(10):1057–1069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3831119</ArticleId><ArticleId IdType="pubmed">24250251</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas I., Khan G.A. Coagulation disorders in COVID-19: role of toll-like receptors. J. Inflamm. Res. 2020;13:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605922</ArticleId><ArticleId IdType="pubmed">33149655</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibamiya A., Hersemeyer K., Schmidt Woll T., Sedding D., Daniel J.M., Bauer S., Koyama T., Preissner K.T., Kanse S.M.A. Key role for toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells. Blood. 2009;113(3):714–722.</Citation><ArticleIdList><ArticleId IdType="pubmed">18971420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding N., Chen G., Hoffman R., Loughran P.A., Sodhi C.P., Hackam D.J., Billiar T.R., Neal M.D. Toll-like receptor 4 regulates platelet function and contributes to coagulation abnormality and organ injury in hemorrhagic shock and resuscitation. Circ. Cardiovasc. Genet. 2014;7(5):615–624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4270899</ArticleId><ArticleId IdType="pubmed">25049041</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonvino S., Melino S. New consensus pattern in spike CoV-2: potential implications in coagulation process and cell-cell fusion. Cell Death Discov. 2020;6:134.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7691694</ArticleId><ArticleId IdType="pubmed">33262894</ArticleId></ArticleIdList></Reference><Reference><Citation>León-Jiménez F.E., Rosas-Ruiz S., Cavalcanti-Ramírez S., Montoya-Reátegui A. Bilateral Chylothorax and COVID-19: report case. Open Respiratory Archives. 2023;5(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9916185</ArticleId><ArticleId IdType="pubmed">37496870</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouche A., De Wispelaere J.-F., Kayser F., Collinge E., Fourneau H. Chylothorax due to central vein thrombosis treated by venous stenting using a dual approach: a case report. Medicine. 2021;100(49)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8663897</ArticleId><ArticleId IdType="pubmed">34889264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>